UFP Technologies, Inc. UFPT R2KR3KPHARMA

Q: What is the current share price of UFP Technologies, Inc. (UFPT)?

As of 2026-09-07 16:24 PDT, UFP Technologies, Inc. (UFPT) trades at $287.40 on NasdaqCM. Its 52-week range is $185.28 to $334.84.

Q: What is the market capitalisation of UFPT?

UFP Technologies, Inc. (UFPT) has a market capitalisation of $2.22B on NasdaqCM.

Q: What is the P/E ratio of UFPT?

UFPT trades at a trailing price-to-earnings (P/E) ratio of 31.04. The industry average P/E is 25.17. Its price-to-book (P/B) ratio is 5.54.

Q: What is the return on equity (ROE) of UFPT?

UFPT has a return on equity (ROE) of 17.05%. Its return on capital employed (ROCE) is 15.91%.

Q: Is UFPT a good stock to buy?

This page provides a data-driven analysis of UFP Technologies, Inc. (UFPT), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Healthcare · Medical Devices · United States

https://www.ufpt.com

Company Profile ↓

$287.40

+26.83% 1Y

Mkt Cap$2.22B

P/E31.04

P/B5.54

52W High$334.84

52W Low$185.28

Book Value$56.73

EPS (TTM)$9.26

Company Overview

UFP Technologies, Inc., together with its subsidiaries, designs and manufactures solutions for medical devices, sterile packaging, and other engineered custom products in the United States. The company provides protective drapes for robotic surgery, patient handling and comfort, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, components for cardiac implants, dispenser coils for catheters, and biopharma drug manufacturing. It also offers equipment protection and packaging for firearms, unmanned aerial vehicles/drones, weapon systems, electronic devices communications equipment, and tools and repair kits; cushion and protective packaging; acoustic and thermal insulation components for automotive, aerospace, consumer, and industrial; filtration for small engines, air conditioners, humidifiers, refrigerators, electronic air cleaners, forced air appliances and industrial compressors; fluid management; and seals and gaskets for automotive manufacturing chemical processing, building and construction applications. In addition, the company provides uniform and tactical gear, such as backpack straps and padding, uniform knee and elbow pads, duty belts, holsters, and helmet padding and others; sports and leisure including custom helmet linings, athletic braces, and shoe insoles; and trim and structural components, consist of load floors, sunshades, package trays, back panel, and seat backs. The company serves the medical, aerospace and defence, automotive, consumer, electronics, and industrial markets. It markets and sells its products through a direct sales force. The company was founded in 1963 and is headquartered in Newburyport, Massachusetts.

Why Investors Should Care

Strong Return on Equity

Generates a return on equity of 17.1%, reflecting efficient use of shareholder capital.

Healthy Capital Returns

Return on capital employed stands at 15.9%.

Consistent Profit Growth

Net profit has compounded at 16.5% per year over the last five years.

Steady Revenue Expansion

Revenue has grown at a 11.9% CAGR over the past five years.

Healthy Margins

Operating margin of 16.2% supports profitability.

Conservative Balance Sheet

Carries low leverage with a debt-to-equity ratio of 0.25.

Recent Developments

Dec 2025 Revenue of $602.80M (+19.5% YoY); net profit $68.31M.
Trailing 12 Months Year-on-year growth — revenue +15.1%, earnings +21.3%.
5-Year Trend Long-term compounding — revenue CAGR 11.9%, profit CAGR 16.5%.

Growth & Price Performance

Compounded Sales Growth

5 Years:	11.94%
1 Year:	15.10%

Compounded Profit Growth

5 Years:	16.50%
1 Year:	21.30%

Stock Price Performance

1 Year:	+26.83%
6 Months:	+37.56%
3 Months:	+28.38%
1 Month:	-7.85%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bullish

52-Week Range 68% of range

$185.28 $334.84

Trend Signals

Price vs 50-DMAAbove
Price vs 200-DMAAbove
RSI (14)44.25 · Neutral

Price Performance

1M-7.85%

3M+28.38%

6M+37.56%

1Y+26.83%

Valuation vs Sector

P/E of 31.04 is above the sector median of 25.17 — pricier than peers.

Auto-generated from price history and fundamentals; not investment advice.

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Period: Metric:

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

Compounding revenue at 11.9% over 5 years.
Profit CAGR of 16.5% over 5 years.
Generates positive free cash flow.
In a confirmed uptrend (50-DMA above 200-DMA).

CONS

No notable concerns flagged.

* The pros and cons are auto-generated from financial metrics.

Valuation

Stock P/E

31.04

Industry PE

25.17

Forward P/E

24.28

PEG Ratio

3.80

Book Value

$56.73

Price to Book

5.54

P/S

3.85

EV/EBITDA

21.90

Dividend Yield

0.00%

Growth (CAGR)

Revenue 5Y

11.94%

Profit 5Y

16.50%

Revenue (YoY)

15.10%

Earnings (YoY)

21.30%

Profitability & Returns

ROCE

15.91%

ROE

17.05%

ROA

9.13%

Profit Margin

11.45%

Op Margin

16.19%

Gross Margin

28.50%

EPS (Latest Qtr)

$2.68

EPS (TTM)

$9.26

Balance Sheet & Liquidity

Debt/Equity

0.25

Quick Ratio

1.56

Current Ratio

3.00

Debt

$117.31M

Total Assets

$681.91M

Current Assets

Working Capital

Ownership

Promoter Holding

3.81%

Chg in Prom Hold

-0.18%

FII / Inst Holding

127.24%

Chg in FII Hold

0.03%

Financial Snapshot

Enterprise Value

$2.22B

Total Revenue (TTM)

$631.64M

EBITDA

$115.84M

Free Cash Flow

$56.94M

Operating Cash Flow

$91.91M

Shares Outstanding

7.74M

Gross Margin

28.50%

Payout Ratio

0.00%

Peer comparison

Peer companies in the same sector (Healthcare).

#	Name	CMP $	P/E	Mkt Cap	Div Yld %	ROCE %	ROE %	Rev CAGR 5Y %	Profit CAGR 5Y %
1	UFPT UFP Technologies, Inc. R2KR3KPHARMA	287.40	31.04	$2.22B	0.00%	15.91%	17.05%	11.94%	16.50%
2	LLY Eli Lilly and Company SPXR3KPHARMA	1,149.36	38.57	$1.02T	0.58%	-	102.29%	7.20%	11.41%
3	JNJ Johnson & Johnson SPXR3KPHARMA	275.23	31.97	$663.28B	2.09%	14.88%	25.74%	2.43%	4.76%
4	ABBV AbbVie Inc. SPXR3KPHARMA	256.46	72.45	$453.19B	2.84%	10.47%	-129.24%	1.75%	-29.06%
5	MRK Merck & Co., Inc. SPXR3KPHARMA	150.33	120.26	$371.29B	2.65%	-	34.70%	5.64%	10.01%
6	UNH UnitedHealth Group Incorporated SPXR3KPHARMA	397.14	25.54	$356.47B	2.33%	9.74%	14.15%	10.40%	5.43%
7	NVS Novartis AG PHARMA	159.99	24.20	$304.10B	3.03%	21.09%	30.35%	9.25%	26.22%
8	AZN AstraZeneca PLC NDXPHARMA	162.70	24.36	$252.33B	1.98%	15.97%	21.96%	9.82%	45.96%
9	AMGN Amgen Inc. NDXSPXR3KPHARMA	437.23	27.14	$235.98B	2.49%	13.95%	91.47%	5.51%	5.55%

Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric	Sep 2016	Dec 2016	Mar 2017	Jun 2017	Sep 2017	Dec 2017	Mar 2018	Jun 2018	Sep 2018	Dec 2018	Mar 2019	Jun 2019	Sep 2019	Dec 2019	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	97.75M	100.04M	100.78M	101.50M	105.01M	110.18M	145.16M	144.07M	148.15M	151.18M	154.56M	148.91M	154.20M	173.96M
Gross Profit	8.45M	8.18M	9.52M	9.94M	8.19M	7.84M	10.19M	12.99M	12.43M	12.71M	12.50M	14.37M	13.32M	13.77M	12.82M	9.95M	10.53M	11.38M	12.61M	13.41M	12.02M	13.07M	17.13M	24.32M	25.52M	23.28M	28.70M	29.64M	27.75M	26.13M	30.08M	33.03M	41.52M	42.06M	42.15M	43.54M	42.75M	41.97M	44.36M	50.92M
Operating Income	4.08M	-	3.21M	3.93M	2.50M	-	2.56M	5.67M	5.88M	-	5.25M	6.57M	6.14M	-	5.08M	2.99M	3.73M	-	5.30M	6.21M	5.08M	-	6.36M	12.20M	25.96M	-	12.84M	17.04M	15.04M	-	15.92M	17.95M	24.76M	-	23.13M	24.33M	23.38M	-	23.37M	28.10M
Net Income	2.67M	-	2.17M	2.63M	1.70M	-	1.78M	3.99M	4.13M	-	3.73M	4.60M	5.64M	-	3.89M	2.32M	2.99M	-	4.16M	4.71M	3.79M	-	4.86M	8.93M	19.54M	-	9.74M	11.88M	11.69M	11.61M	12.69M	13.55M	16.36M	16.38M	17.18M	17.18M	16.38M	17.57M	17.50M	20.85M
Diluted EPS	0.37	0.20	0.30	0.36	0.23	0.37	0.24	0.54	0.56	0.59	0.00	0.62	0.75	0.77	0.52	0.31	0.40	0.55	0.55	0.62	0.50	0.42	0.64	1.17	2.56	1.10	1.27	1.55	1.52	1.51	1.64	1.75	2.11	2.10	2.21	2.21	2.11	2.25	2.24	2.68

Profit & Loss (Annual)

Figures in USD.

Metric	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Revenue	99.23M	120.77M	127.24M	130.96M	139.22M	139.31M	138.85M	146.13M	147.84M	190.46M	198.38M	179.37M	206.32M	353.79M	400.07M	504.42M	602.80M
Gross Profit	26.72M	34.62M	36.24M	38.32M	41.01M	36.88M	37.45M	34.65M	35.49M	48.31M	53.96M	44.68M	51.11M	90.26M	112.22M	146.69M	170.41M
Operating Income	8.19M	14.39M	15.72M	16.67M	17.40M	11.56M	11.71M	12.24M	11.69M	19.61M	24.71M	16.73M	21.22M	55.40M	57.66M	80.90M	92.34M
Net Income	5.93M	9.25M	10.35M	10.89M	11.28M	7.56M	7.59M	7.97M	9.21M	14.31M	19.75M	13.37M	15.89M	41.79M	44.92M	58.98M	68.31M
Diluted EPS	0.94	1.37	1.48	1.55	1.59	1.05	1.05	1.10	1.26	1.93	2.63	1.77	2.09	5.45	5.83	7.58	8.75
R&D Expense	-	900.00K	1.20M	1.30M	1.20M	1.40M	1.30M	1.30M	5.00M	10.50M	8.80M	8.20M	8.50M	9.30M	7.20M	10.40M	8.60M

Balance Sheet (Annual)

Figures in USD.

Metric	Dec 2008	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Assets	-	-	69.48M	79.72M	98.62M	104.91M	112.55M	119.64M	127.93M	138.21M	189.60M	188.76M	203.20M	334.13M	378.19M	404.14M	629.00M	655.08M
Total Equity	31.89M	39.01M	49.70M	61.31M	73.26M	85.59M	94.99M	103.57M	113.05M	123.71M	140.46M	161.99M	176.89M	194.45M	237.54M	286.09M	342.76M	423.88M
Cash & Equivalents	5.14M	13.40M	22.10M	29.85M	33.48M	37.30M	34.05M	29.80M	31.36M	37.98M	3.24M	3.74M	24.23M	11.12M	4.45M	5.26M	13.45M	20.30M
Long Term Debt	-	-	6.85M	5.64M	8.31M	2.87M	1.87M	859.00K	856.00K	-	22.29M	-	0	71.00M	51.00M	28.00M	176.88M	122.95M
Total Liabilities	-	-	19.25M	17.74M	25.36M	19.32M	17.56M	16.06M	14.88M	14.49M	49.14M	26.77M	26.31M	139.69M	140.65M	118.05M	286.24M	231.20M
Current Liabilities	-	-	10.17M	9.47M	13.23M	12.32M	11.61M	10.67M	9.56M	9.94M	20.66M	16.78M	15.14M	38.78M	55.96M	58.21M	76.30M	74.86M

Cash Flows (Annual)

Figures in USD.

Metric	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Operating Cash Flow	-	-	-	-	-	-	12.52M	9.31M	17.47M	21.32M	31.23M	25.04M	14.29M	17.74M	41.33M	66.59M	91.91M
Investing Cash Flow	-	-	-	-	-	-	-15.69M	-7.19M	-10.38M	-82.33M	-5.77M	-4.26M	-101.46M	1.29M	-10.49M	-210.16M	-27.60M
Financing Cash Flow	-	-	-	-	-	-	-1.08M	-559.00K	-475.00K	26.27M	-24.95M	-285.00K	74.05M	-25.89M	-30.02M	152.39M	-58.16M
Capital Expenditure	-1.86M	-3.29M	-3.74M	-11.99M	-5.83M	-13.44M	-15.74M	-7.21M	-10.38M	-5.43M	-5.78M	-4.37M	-5.39M	-13.78M	-10.49M	-9.66M	-
Free Cash Flow	-	-	-	-	-	-	-3.22M	2.10M	7.09M	15.89M	25.45M	20.67M	8.90M	3.96M	30.84M	56.94M	-
Share Buybacks	-	-	-	-	-	-	587.00K	-	-	-	-	-	-	-	-	-	-

Ratios (Annual)

Figures in %.

Metric	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Gross Margin %	26.9%	28.7%	28.5%	29.3%	29.5%	26.5%	27.0%	23.7%	24.0%	25.4%	27.2%	24.9%	24.8%	25.5%	28.1%	29.1%	28.3%
Operating Margin %	8.3%	11.9%	12.4%	12.7%	12.5%	8.3%	8.4%	8.4%	7.9%	10.3%	12.5%	9.3%	10.3%	15.7%	14.4%	16.0%	15.3%
Net Margin %	6.0%	7.7%	8.1%	8.3%	8.1%	5.4%	5.5%	5.5%	6.2%	7.5%	10.0%	7.5%	7.7%	11.8%	11.2%	11.7%	11.3%
ROE %	15.2%	18.6%	16.9%	14.9%	13.2%	8.0%	7.3%	7.0%	7.4%	10.2%	12.2%	7.6%	8.2%	17.6%	15.7%	17.2%	16.1%
ROCE %	-	24.3%	22.4%	19.5%	18.8%	11.5%	10.8%	10.3%	9.1%	11.6%	14.4%	8.9%	7.2%	17.2%	16.7%	14.6%	15.9%

Shareholding Pattern

Insiders

3.81%

Institutions

127.24%

Public Float

132.28%

Top Institutional Holders

#	Holder	% Held	Shares	Value
1	Blackrock Inc.	14.74%	1.14M	$342.48M
2	Congress Asset Management Co	8.88%	687.44K	$206.27M
3	Wasatch Advisors LP	8.82%	683.26K	$205.01M
4	Neuberger Berman Group, LLC	6.93%	537.04K	$161.14M
5	Price (T.Rowe) Associates Inc	4.61%	357.33K	$107.22M
6	Boston Trust Walden Corporation	4.34%	336.28K	$100.90M
7	Vanguard Capital Management LLC	4.26%	329.62K	$98.90M
8	State Street Corporation	4.04%	312.81K	$93.86M
9	American Century Companies Inc	3.61%	279.98K	$84.01M
10	UBS Group AG	3.29%	254.74K	$76.43M

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for UFPT

Google News Sun, 06 Sep 2026

Why UFP Technologies (UFPT) Is Getting Attention Now - simplywall.st

<a href="https://news.google.com/rss/articles/CBMixgFBVV95cUxNTGxCbWszMG4yMDFBd0lzMEtKaTB5VzUwZzNaaURLTXpCcHFaYkVqcHYtelVLSjZiZlNzYlNrWnlESUFIbG0tV19MYk9jRk9jdGh3cjRGTDhDNnhIaFpwbndlSEFMeVJsdkFWekRESDhJNmoxWnphME90S2pOWDV1U0tlX3hBaldZdy0xQk…

Google News ue, 04 Aug 2026

Why Is UFP Technologies (UFPT) Stock Soaring Today - StockStory

<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxPMXpQRXkza2c1VTV6MlpjcTBVajNUVTAxWWg2R0M4ZXdTb1Z5UFU2SF9PZW5GWG1GMmc0NVZZVkpYWTM0MzdqMlJROXdIVjhfUDlMZUZnVk1zQlltNFd1d2xsOVhGcDNaNzc2SjVWQ1ZqdERjN29HX0s0eDRfbEI4Q2FBYU44Ti02WmM3SF…

Google News hu, 03 Sep 2026

UFP Technologies (UFPT) Posts Record Profits, But The Margin Story Gets Complicated - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxObGU5WGJ1TWxOUV9pOUdmYTNkc0FrUGdMU3YxckJvdDl0dlpkTXBnMXNwTWxrQTV2TzFIazVMSzg0N1E4dF9OelNPaS1FVTlMZFNBV0VSeFNETVQ2WmFDc2k3SDhrRTRDYmoyZERQY3pIcmJuRFRjV25BVGl1eDBwUEJidDFmaERaTVp0NC…

Google News Fri, 04 Sep 2026

Legal & General Group Plc Invests $4.78 Million in UFP Technologies, Inc. $UFPT - marketbeat.com

<a href="https://news.google.com/rss/articles/CBMizgFBVV95cUxNWFJtQzM3UVBKNkowRnVmTjJQVUEtYXJIMmpUVmNtcEFyQ25mSjhEbHhESnFNYVN5aGRsMU8wdktBR3ZGbFF1Vk1FbW9JYnJudE15VlIxRklmd1FTd3JPVmFHWWkyUnlPSDBqT3FrV2JITWlENExPSUgyaFNJMXk5SjdobS1qbEJ5TDNFSj…

Google News hu, 03 Sep 2026

Trading Systems Reacting to (UFPT) Volatility - Stock Traders Daily

<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxNMENoXzdlUHdwX1FIR3AzbnNEX3FHdndnTGNlS3c0X2hTVUJOeGs3UERYYUhsM1VZOXNLVHpfVC1FTUNXbUFMOVJ4Y0d0QUZoTmg0aE5odlBhcGVpbWdIUWFoVlhNMFNTRTVVdW1sekl5c21DSHlHdWRWbFVKblpwcW9BRFNjWnJ2WFM4M1…

Google News ue, 25 Aug 2026

UFP Technologies (NASDAQ: UFPT) director to sell 7,000 shares via trust - Stock Titan

<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxPb3pwT1hqRTgtTGRGWDJaQ1c3MkFuZTBFMC1TVkl4VlduVnZYejJvczVDTXRPMkVYUkdIb1c0b2RhcXY3S0F2MmhMYjRLUF9WYVNCTVliVUlfam9CSWF3RGhyelBKWDJwOXdLOF84a2ROZVdMa25vVmFwRngxbVg5aUJ0S1RqN21oWnNDQ2…

UFPT — Frequently Asked Questions

What is the current share price of UFP Technologies, Inc. (UFPT)?

As of 2026-09-07 16:24 PDT, UFP Technologies, Inc. (UFPT) trades at $287.40 on NasdaqCM. Its 52-week range is $185.28 to $334.84.

What is the market capitalisation of UFPT?

UFP Technologies, Inc. (UFPT) has a market capitalisation of $2.22B on NasdaqCM.

What is the P/E ratio of UFPT?

UFPT trades at a trailing price-to-earnings (P/E) ratio of 31.04. The industry average P/E is 25.17. Its price-to-book (P/B) ratio is 5.54.

What is the return on equity (ROE) of UFPT?

UFPT has a return on equity (ROE) of 17.05%. Its return on capital employed (ROCE) is 15.91%.

Is UFPT a good stock to buy?

This page provides a data-driven analysis of UFP Technologies, Inc. (UFPT), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks

UFP Technologies, Inc. UFPT R2KR3KPHARMA

Company Overview

Why Investors Should Care

Recent Developments

Growth & Price Performance

Compounded Sales Growth

Compounded Profit Growth

Stock Price Performance

Price Chart

Technical Trend

Fundamental Growth Charts

PROS

CONS

Valuation

Growth (CAGR)

Profitability & Returns

Balance Sheet & Liquidity

Ownership

Financial Snapshot

Peer comparison

Quarterly Results

Profit & Loss (Annual)

Balance Sheet (Annual)

Cash Flows (Annual)

Ratios (Annual)

Shareholding Pattern

Top Institutional Holders

Analyst View

Latest News

Why UFP Technologies (UFPT) Is Getting Attention Now - simplywall.st

Why Is UFP Technologies (UFPT) Stock Soaring Today - StockStory

UFP Technologies (UFPT) Posts Record Profits, But The Margin Story Gets Complicated - Yahoo Finance

Legal & General Group Plc Invests $4.78 Million in UFP Technologies, Inc. $UFPT - marketbeat.com

Trading Systems Reacting to (UFPT) Volatility - Stock Traders Daily

UFP Technologies (NASDAQ: UFPT) director to sell 7,000 shares via trust - Stock Titan

UFPT — Frequently Asked Questions

What is the current share price of UFP Technologies, Inc. (UFPT)?

What is the market capitalisation of UFPT?

What is the P/E ratio of UFPT?

What is the return on equity (ROE) of UFPT?

Is UFPT a good stock to buy?

Explore More